Summit Therapeutics Inc. (SMMT)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
13. 81
+0.05
+0.3634%
$
12.01B Market Cap
- P/E Ratio
- Div Yield
2.84M Volume
0 Eps
$ 13.76
Previous Close 
Want to track SMMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summit Therapeutics Inc. (SMMT) Statistics
Valuation metrics
Market Cap 12.01B
Enterprise value 10.65B
Trailing P/E (ttm) -9.86
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) -
Price/Book (mrq) 25.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA -10.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.83M
Average volume (90 days) 5.3M
Price summary
52-Week low 12.55
52-Week high 30.98
Beta -
50-Day moving average 14.09
200-Day moving average 17.27
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.14%
Return on equity -3.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 7.41%
Book value per share (mrq) 0.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
